Filing Details

Accession Number:
0001104659-22-063798
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-23 14:46:44
Reporting Period:
2022-05-12
Accepted Time:
2022-05-23 14:46:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1563665 Biostage Inc. BSTG () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1505051 E. James Shmerling C/O Biostage, Inc.
84 October Hill Road, Suite 11
Holliston MA 01746
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-12 16,892 $5.92 16,892 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants (right to buy) Acquisiton 2022-05-12 8,446 $0.00 8,446 $8.88
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,446 2022-05-12 2027-05-12 No 4 P Direct
Footnotes
  1. On May 12, 2022, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 16,892 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 8,446 shares of common stock with an exercise price of $8.88 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $100,000.